Jing Zhao

发表

Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer

Yan Xu, W. Zhong, Mengzhao Wang, 2022, Frontiers in Immunology.

Neoadjuvant immunotherapy followed by surgery with curative intent in 35 patients with advanced NSCLC: the retrospective experiences of a multidisciplinary team

Hongsheng Liu, D. Ma, Shanqing Li, 2021, Annals of translational medicine.

Prognostic Factors and Survival Benefits of Antitumor Treatments for Advanced Non-Small Cell Lung Cancer Patients With Central Nervous System Metastasis With or Without Driver Genes: A Chinese Single-Center Cohort Study

W. Zhong, Mengzhao Wang, Yan Xu, 2022, Frontiers in Oncology.

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced diabetes mellitus

Xiaoyan Liu, W. Zhong, Mengzhao Wang, 2022, Translational oncology.

Risk of progression in patients with chronic atrophic gastritis: A retrospective study

Hai-Feng Jin, Lu Sun, Jing Zhao, 2022, Frontiers in Oncology.

Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatments

J. Jassem, M. Provencio, Xiaoyan Liu, 2021, Translational lung cancer research.

Feasibility and reliability of evaluate PD‐L1 expression determination using small biopsy specimens in non‐small cell lung cancer

W. Zhong, Mengzhao Wang, Ji Li, 2021, Thoracic cancer.

Leptomeningeal enhancement in magnetic resonance imaging predicts poor prognosis in lung adenocarcinoma patients with leptomeningeal metastasis

W. Zhong, Mengzhao Wang, Yan Xu, 2022, Thoracic cancer.

The development of a tumor‐associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor‐based treatment in patients with advanced non‐small‐cell lung cancer

W. Zhong, Mengzhao Wang, Yan Xu, 2023, Thoracic cancer.

A sensitive and practical method to detect the T790M mutation in the epidermal growth factor receptor.

W. Zhong, Mengzhao Wang, Yan Xu, 2016, Oncology letters.

Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer

Shanqing Li, W. Zhong, Mengzhao Wang, 2022, Frontiers in Immunology.

[Detection of EGFR gene mutations in 100 non-small cell lung cancer clinical samples by a real-time polymerase chain reaction method using amplification refractory mutation system specific primers and Taqman fluorescence probes].

Li Zhang, J. Zhao, Weijun Chen, 2013, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

754例Ⅰ期-Ⅲa期可手术切除非小细胞肺癌患者EGFR和KRAS基因突变状态及其临床意义

Jie Gao, Zhiyong Liang, Li Zhang, 2017, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Gut microbiota composition in patients with advanced malignancies experiencing immune-related adverse events

Yue Li, Yan Xu, B. Tan, 2023, Frontiers in Immunology.

Circulating cytokines associated with clinical outcomes in advanced non‐small cell lung cancer patients who received chemoimmunotherapy

Juan Du, Xiaoyan Liu, W. Zhong, 2021, Thoracic cancer.

Risk factors for immune-related adverse events: what have we learned and what lies ahead?

Xiaoyan Liu, W. Zhong, Mengzhao Wang, 2021, Biomarker Research.

Comparison of Chemotherapy Plus Pembrolizumab vs. Chemotherapy Alone in EGFR-Mutant Non-small-Cell Lung Cancer Patients.

Yan Xu, W. Zhong, Mengzhao Wang, 2022, Clinical lung cancer.

Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis

Wei Wu, Hao Qian, Xiaoyan Liu, 2022, Cancer communications.

Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastases

W. Zhong, Mengzhao Wang, Yan Xu, 2023, Translational oncology.

Circulating tumor cells PD‐L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non‐small‐cell lung cancer

Xiaoyan Liu, W. Zhong, B. Tong, 2023, Thoracic cancer.

The microbiome types of colorectal tissue are potentially associated with the prognosis of patients with colorectal cancer

Dongshen Ma, Hui Liu, Chenxi Xiang, 2023, Frontiers in Microbiology.

Real-World Data of Different Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer in China

Yan Xu, W. Zhong, Mengzhao Wang, 2022, Frontiers in Oncology.

小细胞肺癌的分子分型及其治疗策略的研究进展

Mengzhao Wang, Jing Zhao, Yangchun Wu, 2023, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?

Hongsheng Liu, D. Ma, Shanqing Li, 2023, Thoracic cancer.

Detection of low-level DNA mutation by ARMS-blocker-Tm PCR.

Weijun Chen, Jie Huang, Mengzhao Wang, 2016, Clinical biochemistry.

Vitamin D Status Is Associated With Immune Checkpoint Inhibitor Efficacy and Immune-related Adverse Event Severity in Lung Cancer Patients: A Prospective Cohort Study

Mengzhao Wang, Yue Li, Yan Xu, 2023, Journal of immunotherapy.

Dynamic gut microbiota changes in patients with advanced malignancies experiencing secondary resistance to immune checkpoint inhibitors and immune-related adverse events

Mengzhao Wang, Yan Xu, B. Tan, 2023, Frontiers in Oncology.

Safety and efficacy of atezolizumab in Chinese patients with previously treated locally advanced or metastatic non-small cell lung cancer: An open-label, single-arm, multicenter study.

Jian-hua Chang, Si Sun, Juan Li, 2023, Lung cancer.

All-shot Aspirations in Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Are Associated With Malignancy

Xuefeng Sun, Mengzhao Wang, C. Shao, 2023, Technology in cancer research & treatment.

Analysis of cytokines in bronchoalveolar lavage fluid in patients with checkpoint inhibitor pneumonitis and pulmonary infection: A case–control study

X. Tian, W. Zhong, Mengzhao Wang, 2023, Thoracic cancer.

Safety and efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients with preexisting antinuclear antibodies: a retrospective cohort study

Jia Liu, N. Horita, M. Provencio, 2021, Translational lung cancer research.

Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC

Jia Liu, W. Zhong, Mengzhao Wang, 2023, Thoracic cancer.

Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers

Jing Zhao, Minjiang Chen, Hongge Liang, 2024, Cancer gene therapy.

The outcomes of different regimens depend on the molecular subtypes of pulmonary large‐cell neuroendocrine carcinoma: A retrospective study in China

W. Zhong, Jing Zhao, Minjiang Chen, 2024, Cancer medicine.

Comparison of radiotherapy versus surgical resection following neoadjuvant chemoimmunotherapy in potentially resectable stage III non-small-cell lung cancer: A propensity score matching analysis.

W. Zhong, Jing Zhao, Minjiang Chen, 2024, Lung cancer.